Group 1 - Chengdu Xian Dao Pharmaceutical Development Co., Ltd. experienced a decline of 5.19% in stock price, reaching 35.46 CNY per share, with a trading volume of 607 million CNY and a turnover rate of 4.17%, resulting in a total market capitalization of 14.208 billion CNY [1] - The company, established on February 22, 2012, and listed on April 16, 2020, specializes in early-stage drug discovery services using its core DEL technology, with 99.97% of its revenue coming from new drug research services [1] - The revenue breakdown includes customized services at 59.92%, full-time equivalent services at 27.20%, and other services at 12.84%, with a negligible 0.03% from supplementary sources [1] Group 2 - According to data from the top ten holdings of funds, Wan Jia Fund has one fund heavily invested in Chengdu Xian Dao, specifically the Wan Jia Quantitative Tongshun A (005650), which held 30,200 shares, accounting for 1.91% of the fund's net value, ranking as the tenth largest holding [2] - The estimated floating loss for the fund today is approximately 58,600 CNY [2] - Wan Jia Quantitative Tongshun A was established on May 4, 2018, with a latest scale of 29.9221 million CNY, achieving a year-to-date return of 7.53% and a one-year return of 37.32% [2]

Core Viewpoint - Chuangli Group (603012.SH) reported its Q3 2025 results, indicating a slight decrease in institutional investor holdings compared to the previous quarter [1] Institutional Holdings - As of October 30, 2025, three institutional investors disclosed holdings in Chuangli Group A-shares, totaling 142 million shares, which represents 21.96% of the company's total equity [1] - The institutional investors include Shanghai Jusheng Investment Co., Ltd., China Coal Machinery Group Co., Ltd., and Shanghai Yingshui Investment Management Co., Ltd. - Yingshui Rixin No. 4 Private Securities Investment Fund [1] - The total institutional holding percentage decreased by 0.09 percentage points compared to the previous quarter [1] Public Fund Holdings - In this reporting period, 29 public funds were not disclosed compared to the previous quarter, including Wanjiaguo Zheng 2000 ETF, CSI 2000, Guojin Quantitative Multi-Factor A, Guojin Quantitative Selected A, and Wanjiaguo Quantitative Tongshun A [1]

Core Viewpoint - Jiashe Technology (300193.SZ) reported its 2025 semi-annual results, highlighting an increase in institutional investor holdings and the presence of public funds and pension funds in its shareholder structure [1] Institutional Holdings - As of August 15, 2025, six institutional investors disclosed holdings in Jiashe Technology, totaling 61.45 million shares, which represents 12.90% of the company's total share capital [1] - The institutional investor group includes Shenzhen Qianxin Heng Investment Development Co., Ltd., Shenzhen Qianhai Yongcheng Asset Management Co., Ltd. - Yongcheng No. 1 Securities Private Fund, and others [1] - Compared to the previous quarter, the total institutional holding percentage increased by 0.26 percentage points [1] Public Funds - Four public funds were disclosed this period, which were not reported in the previous quarter, including Anxin Quantitative CSI 300 Enhanced A and others [1] Pension Funds - One pension fund increased its holdings compared to the previous period, specifically the Basic Pension Insurance Fund 1003 Combination, with an increase in holding percentage of 0.3% [1]